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When pediatric patients are admitted to the inpatient or outpatient hospital setting they 
potentially have to endure procedures that cause pain, fear, and anxiety which can have a 
lifelong impact on the child’s response to future healthcare needs. The purpose of this 
project was to create a comprehensive program proposal for a nitrous oxide sedation 
program to minimize those perceptions towards medical procedures. The project utilized 
a systematic review of literature and secondary data to address the most important 
indicators for developing a comprehensive program proposal to present to the pediatric 
leadership team. Multiple studies have shown nitrous oxide having an excellent safety 
profile in the pediatric population while providing an almost pain and anxiety free 
procedure. The program proposal will be used to improve pain and anxiety management 
for pediatric patients requiring procedures such as intravenous access, venipuncture, 
voiding cystourethrograms, lumbar puncture, bone marrow biopsy, port-a-cath access, 
PICC line insertion, dressing changes, chest tubes, and wound care. Key stakeholders and 
content experts were brought together to create the nitrous oxide program proposal which 
included a new practice guideline, a comprehensive policy and procedure for nitrous 
oxide administration, and an education plan. The program proposal included other key 
components necessary for a safe and efficient program such as a pre-assessment to 
determine if the child is a candidate, monitoring and documentation of nitrous oxide 
administration, and education for the child/parent(s). The nitrous oxide program for 
pediatrics was designed as a minimal sedation method to minimize procedural pain, fear, 
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Section 1: Overview of the Evidence-Based Project 
Introduction and Background  
Pediatrics is defined as a field of medicine that is concerned with the health of 
infants, children, and adolescents: their growth and development and the conditions that 
allow them to achieve full potential as adults (American Academy of Pediatrics [AAP], 
n.d.). According to the United States Census Bureau’s 2011 data, there are 74 million 
children who live in the United States (U.S. Census Bureau, 2014). There were 25.5 
million under the age of six, 24.9 million aged six to 11 years, and 23.8 million aged 12-
17 years (U.S. Census Bureau, 2014). The percentage of the total population under the 
age of 18 is projected to decrease from 23% to 20% between 2014 and 2060 (Colby & 
Ortman, 2015). 
Hospital admissions can be very stressful for children and their parents. 
Hospitalizations can cause a great deal of emotional stress, especially in children, where 
the anxiety from being away from their home environment can be traumatic (Macías et 
al., 2015). Children will often miss their normal routines, interactions with their peers, 
their families, and even their pets. Stress in children is usually caused by experiences that 
are unfamiliar or unpredictable. These situations may present unclear expectations that 
cause a fear of failing, or create anticipation of something unpleasant (Washington, 
2009). Children often demonstrate negative reactions, including aggressive behaviors, 
withdrawal from caregivers or family, becoming uncooperative, and showing difficulty 
coping with and/or recovering from procedures performed in the hospital or outpatient 
settings. These types of distress can interfere with the delivery of needed medical 




found that when anxiety is decreased, children are able to approach medical situations 
with a sense of comfort, achievement, and control. A suggested method to help alleviate 
pain, anxiety, or fear associated with medical procedures in children is the use of inhaled 
nitrous oxide.  
Factors such as fear, anxiety, coping difficulties, and lack of social support can 
further exaggerate the physical pain in children (Verghese & Hannallah, 2010). The use 
of basic ethical principles can help nurses make evidence-based decisions that provide 
optimal pain treatment for the pediatric patient (Bernhofer, 2011). Pediatric patients are 
patients at a high risk for inadequate pain management. Pain assessments may be 
complex due to the subjective nature of information received from the patient. Utilizing 
ethical principles of autonomy, beneficence, nonmaleficence, and justice may help the 
nurse advocate for the patient’s pain relief needs. Nitrous oxide sedation for anxiolysis is 
a method providers can suggest to the patient/parent(s) to use to reduce pain, fear, and 
anxiety associated with noninvasive, minimally invasive, and invasive procedures during 
hospitalizations in the pediatric departments and in the outpatient pediatric 







Figure 1. Categorization of procedures 
 
Nitrous oxide sedation has been proven to be a safe and effective method of 
reducing pain and anxiety in patients and has been around for over 200 years. Nitrous 
oxide was discovered in the late 1770s by Sir Joseph Priestley. Priestly discovered N₂O 
through experiments on nitrous air which was a mixture of iron filings, sulfur, and water 
(Clark & Brunick, 2015). Humphrey Davy went on to experiment with N₂O and found 
the gas provided the sensation of pleasure, joy, and euphoria, and he felt like laughing 
(Clark & Brunick, 2015). During Davy’s experiments, he experienced pain relief of a 
toothache from the N₂O gas; it was at that point where he began to believe that the gas 
could have some anesthetic properties (Clark & Brunick, 2015). Over the next few 





the gas were not pursued. It wasn’t until the 1840s that the anesthetic value of N₂O was 
considered again. Dr. Horace Wells, a dentist, began using the gas for tooth extractions in 
his dental office after he breathed the gas himself and had a colleague extract one of his 
own teeth (Clark & Brunick, 2015; Ellis, 2015). Wells was recognized by the American 
Dental Association (ADA) as the primary discoverer of anesthesia (Clark & Brunick, 
2015).   
Nitrous oxide has remained in continuous use longer than any other drug and has 
never been replaced by something different; it continues to be used during procedural 
sedation for pain and anxiety relief in patients undergoing invasive procedures, and it has 
a remarkable safety record (Clark & Brunick, 2015). Nitrous oxide has been primarily 
used in dentistry but has also been used in emergency medicine, podiatry, labor and 
delivery, radiology, and as a sedation treatment for procedures not requiring general 
anesthesia (Farrell et al., 2008). Over the years, procedural sedation and analgesia have 
grown and have been further advanced by new drugs and monitoring technologies, 
expanded practitioner skills, the need to shift procedural work to outpatient settings, and 
widespread acceptance of the ethical guidelines to treat pain and anxiety in children 
(Krauss & Green, 2006). 
Problem Statement 
Healthcare professionals who work with children frequently claim that “children 
are not little adults” and have special physiologic and developmental needs; however, this 
is often ignored when it comes to pain and sedation management in children. According 
to the AAP and the American Pain Society (APS, 2001), there is much evidence that pain 




many “routine” nursing procedures, including venipunctures, IV starts, and bladder 
catheterizations. Many such procedures are capable of producing a state of panic in 
children (Herd, 2008). Distress and anxiety can actually increase the child’s perception of 
pain (Rodriguez, Clough, Gowda, & Tucker, 2012). According to Zempsky (2008), 
pediatric patients report IV placement as the leading cause of procedure-related pain in 
the hospital. One study discussed by Kennedy, Luhmann, and Zempsky (2008) surveyed 
2,188 pediatric, emergency, and infusion nurses and found that children were physically 
restrained during IV insertion 74% of the time. Although topical anesthetics such as 
lidocaine 2.5%/prilocaine 2.5% (EMLA) and intervention by the child life specialists are 
valuable tools in this practice area, they are not always enough to gain the cooperation of 
a frightened child (Ekbom, Jakobsson, & Marcus, 2005).  
Nitrous oxide is a clear, odorless gas with sedative, amnestic, and mild analgesic 
properties (Farrell et al., 2008). It has been used safely to provide conscious sedation 
without loss of verbal contact with the child in a number of settings and for a variety of 
procedures. The goal of this project was to develop an evidence-based N₂O program for 
pediatric and pediatric hematology/oncology patients for inpatient and outpatient 
procedures. The proposed plan is to expand the pediatric sedation program with the 
addition of N2O as a single sedative agent for anxiolysis/analgesia use in the sedation 
program. The administration of minimal, moderate, and deep sedation is an integral part 
of pediatric hematology/oncology practice. Procedural sedation is the technique of 
administering sedatives or dissociative agents with or without analgesics to put the 
patient in a state where they are able to tolerate painful or unpleasant procedures while 




Nitrous oxide is an analgesic that is administered for the pediatric population to 
reduce fear, anxiety, and pain response during minor invasive procedures. Nitrous oxide 
administration would be a very beneficial addition to the sedation program for patients in 
a pediatric setting. A majority of the children in the pediatric department are oncology 
patients. Children who are diagnosed with cancer go through procedures such as lumbar 
punctures, bone marrow biopsy and aspirations, placement of a central line at the 
beginning of treatment and removing it at the end of treatment, dressing changes, port 
access for chemotherapy and other medications, and/or IV starts during the course of 
their treatment. Nitrous oxide administration provides for an almost pain and anxiety-free 
procedure, requires neither an intravenous line nor postprocedure monitoring, and 
minimizes any unpleasant memories the child may have (Burnweit et al., 2004). 
Context  
The environment selected for the nitrous oxide program proposal is the HSHS St. 
Vincent Children’s Hospital which is located within HSHS St. Vincent Hospital. The 
population of patients for the DNP Project will be pediatric patients undergoing painful 
and anxiety provoking procedures, specifically in the inpatient pediatric department, the 
pediatric intensive care unit, and the outpatient pediatric hematology/oncology clinic. 
Children admitted to HSHS St. Vincent Children’s Hospital are cared for in one of two 
pediatric locations within the 24-bed Children’s Hospital inpatient units, not including the 
neonatal intensive care unit (NICU), depending on the severity of illness or injury. The 
pediatric intermediate care unit (PIMCU) cares for general admissions and those patients 
requiring closer observation. The pediatric intensive care unit (PICU) is reserved for 




intensivists. The pediatric department and the PICU are located on the same floor, 
making the transition from one unit to another easier for both patients and their families. 
HSHS St. Vincent Children’s Hospital also includes an outpatient pediatric 
hematology/oncology clinic that provides care to children who have cancer or blood 
disorders. The clinic is located in a different area of the host hospital; however it is an 
easy transition for children who are admitted for chemotherapy treatments, illness or 
complications due to chemotherapy, and children needing treatment for bleeding 
disorders. The HSHS St. Vincent Children’s Hospital is also affiliated with Prevea Health 
Care where pediatric patients can be seen by their regular pediatrician for well-child 
checks or referred to other providers.  
The total inpatient days for pediatrics, PICU, and NICU during the 2015 fiscal 
year was 10,371. This excludes the routine newborn population, since that population is 
part of the women’s center. The number of pediatric ambulatory/short stay visits for the 
2015 fiscal year was 1,075. There were 768 patients from the pediatric 
hematology/oncology clinic during the fiscal year; however this number does not include 
nonprovider visits. The nonprovider visits are nurse-only visits which include routine lab 
checks, blood or platelet transfusions, intravenous immunoglobulin (IVIG) infusions, or 
port-a-cath needle changes or flushes. The pediatric gastrointestinal clinic saw 570 
patients (this is partial year data). The pediatric subspecialty clinics saw 4,369 patients 
during the fiscal year and the Prevea Health pediatric primary clinics saw a total of 
50,096 patients in the 2015 fiscal year.  
The HSHS St. Vincent Children’s Hospital also has a pediatric procedural 




undergoing both inpatient and outpatient procedures such as MRIs and CT scans, lumbar 
punctures, and bone marrow biopsies and aspirations. Children requiring such procedures 
usually are admitted in the morning, undergo the procedure, and are discharged the same 
day. A pediatric intensivist and a PICU nurse attend to the patient throughout the 
procedure, and the child is monitored until full recovery, usually in the PIMCU. The 
same process occurs in the pediatric hematology/oncology clinic. The nurses in the 
pediatric hematology/oncology clinic are trained to monitor patients receiving moderate 
sedation as well as recover patients receiving moderate or deep sedation.  
Over the last two years (11/1/2013-12/1/15) the pediatric procedural sedation 
team has performed 833 cases. A majority of the sedation cases were done for children 
who had cardiovascular disorders, developmental delays, infections, leukemia, seizure 
disorders, hematology/oncology disorders, and neurological disorders. The top primary 
problems were leukemia (217 cases), seizure disorders (117 cases), hematology/oncology 
disorders other than leukemia (129 cases), and neurological disorders (213 cases). The 
pediatric intensivists performed 725 cases and 106 cases were performed by pediatric 
subspecialists (e.g., RN staff in the pediatric hematology/oncology clinic). The 
procedures performed included bone marrow biopsies (43), Botox injections (7), 
bronchoscopies (5), cardiac echocardiograms(19), CT scans (28), EEGs (68), EMGs (8), 
joint injections (6), lumbar punctures for diagnostic or therapeutic reasons (48), lumbar 
punctures for chemotherapy administration (196), MRIs (366), PICC line placement (20), 
renal or bone scans (19), voiding cystourethrograms (14), radiology tests (25), and other 
painful procedures not specified (69). The medications used for the procedures include 




fentanyl (194 instances), morphine (110 instances), and lidocaine as well as 471 instances 
of the topical anesthetic 2.5% lidocaine/2.5% prilocaine (EMLA). Many of the 
procedures used either deep sedation or moderate sedation depending on the child’s 
developmental age, anxiety towards the procedure, or parental request. The pediatric 
sedation program does not have a minimal sedation method. The above procedures can be 
performed utilizing N₂O (minimal sedation) because they are relatively short procedures. 
Nitrous oxide can be used effectively for short procedures and has a shorter recovery time 
than both moderate and deep sedation methods.  
There were minimal side effects or complications seen with the sedation cases, 
which involved airway obstruction (18 cases), apnea >15 seconds (2 cases), coughing (14 
cases), desaturation/hypoxia (15 cases), IV related complications (3 cases), requirement 
of emergent airway intervention (3 cases), snoring/partial obstruction (25 cases), stridor 
(3 cases), and unexpected change in heart rate or blood pressure >30% (2 cases). There 
were 769 cases without any side effects or complications.  
HSHS St. Vincent Hospital is an acute care hospital within the Hospital Sisters 
Health System, which is a multi-institutional health care system comprised of 14 
hospitals and is the host hospital for the HSHS St. Vincent Children’s Hospital. HSHS St. 
Vincent is a 255 bed hospital including adult intensive care, cardiovascular (heart center), 
emergency, gynecology, hospice/palliative care, neurology, obstetrics (women’s center), 
oncology, orthopedics, pulmonary, rehabilitation/physical medicine, trauma, 
urology/nephrology, palliative care, dialysis, and a stroke center (HSHS St. Vincent 




Purpose Statement  
The purpose of developing a N₂O program for pediatrics is to provide anxiolysis 
and analgesia via an inhaled N₂O delivery system for pediatric patients undergoing 
painful procedures or procedures that cause anxiety or fear. Statistics show that nearly 35 
million people in the United States avoid procedures because of fear and anxiety (Clark 
& Brunick, 2011). Fear of pain can be a huge obstacle to overcome, especially in the 
pediatric patient. Invasive diagnostic and minor surgical procedures on pediatric patients 
outside the traditional operating room setting have increased in the last decade and as a 
consequence, the need for sedation for procedures in physician offices, dental offices, 
subspecialty procedure suites, imaging facilities, emergency departments, and ambulatory 
surgery centers has also significantly increased (Cote & Wilson, 2008).  
Nitrous oxide sedation has primarily been used in dental practices. When used for 
dental procedures in children, N₂O is typically used in longer dental procedures to 
provide analgesia/anxiolysis to expedite the completion of procedures that are not 
comfortable for the child (American Academy of Pediatric Dentistry [AAPD] Council on 
Clinical Affairs, 2013). Using N₂O for the pediatric patient may allow the patient to 
tolerate an uncomfortable dental procedure by relieving anxiety, fear, discomfort, or pain 
(AAPD Council on Clinical Affairs, 2013). According to Krall (2011), nitrous oxide can 
be administered in procedures such as diagnostics (x-ray films, clinical exams), minor 
procedures (impressions, placement of orthodontic bands, suture removal), periodontal 
(probing, scaling, root planning), restorative (fillings, crown, bridge), and surgical 




Project Premise.  
The premise of the project included development of a comprehensive program 
proposal for an alternative method for pain and anxiety management in pediatric patients 
to be used to inform the interprofessional Pediatric Policy Committee. A question 
addressed by the project premise was: Will administering N₂O to pediatric patients 
provide a safe, effective, comparable option to moderate sedation in reducing anxiety and 
assessed or reported pain scores during invasive, potentially painful procedures?.  
Program Objectives  
The outcomes addressed for the N₂O program are: 
1. Provide a comprehensive program proposal with recommended policies and 
procedures.  
2. Provide patient/family education materials that would inform families of 
nitrous oxide use. 
3. Present the Nitrous Oxide Program Proposal Project packet to the decision-
making body, which would include the leaders within the pediatric 
departments and the pediatric intensivists. 
Using N2O as an analgesic in a sedation program provides for an almost pain and 
anxiety-free procedure, and it can minimize any unpleasant memories the child may have 
with the procedure (Burnweit et al., 2004). Rather than a moderate or deep sedation 
method, N2O can be used for many different pediatric procedures, including lumbar 
punctures, bone marrow aspirations, dressing changes, IV starts, port-a-cath access, or 
wound care and it has been established world-wide as an analgesic method for painful 




stay would be reduced for patients and their families because the recovery from N2O is 
about 5 minutes versus 1 hour or longer for moderate or deep sedation (Clark & Brunick, 
2015). Nitrous oxide administration has been proven to be safe minimal sedation option 
as compared to moderate or deep sedation. Treatment with N₂O is a well-established 
method for pain alleviation in children (Burton, Auble, & Fuchs, 1998; Cleary et al., 
2002; Annequin et al., 2000; Krause & Green, 2006) and has been used with good results, 
in particular in children who fear the dentist (AAPD, 2013). Nitrous oxide has an 
excellent safety record, has a relative ease of use, and has minimal effect on a patient’s 
physiological function, making it a very versatile and safe sedative agent (Krall, 2011).  
New policies and procedures, administration guidelines, documentation and 
monitoring tools, fasting guidelines, patient and family education information packets for 
staff, plan for staff training, and preprocedure, during procedure, and postprocedure 
pain/anxiety assessment tools were incorporated into a comprehensive protocol proposal 
for an evidence-based N₂O program for the HSHS St. Vincent Children’s Hospital. New 
practice strategies created from this project could be placed into the pediatric 
department’s strategic plan for the future, and budgets could be planned to maintain 
equipment, training, and gas needed for nitrous administration. 
The DNP project for developing a proposal package for the N₂O program will 
reflect objectives from the Essentials of Doctoral Education for Advanced Nursing 
Practice from the American Association of Colleges for Nursing (AACN): (a) 
underpinnings for practice, (b) organizational and systems leadership for quality 




based practice (EBP), (d) information systems and technology, (e) policy for advocacy, 
(f) and inter-professional collaboration (AACN, 2006). 
Significance to Practice 
Sedation for children is very different from sedation of adults due to physiology 
and age-related developmental factors. When sedation is administered in the pediatric 
patient, it is usually done to control behavior to safely complete the procedure.  A child’s 
ability to control his or her behavior and cooperate for a procedure depends both on 
chronologic and developmental age (AAPD, 2013). Children younger than six years and 
those with developmental delay may require a deep level of sedation to control their 
behavior for the procedure (AAPD, 2013).  
An alternative sedation method is the administration of inhaled N₂O. Nitrous 
oxide has rapid onset (30–60 seconds), maximum effect after about 5 minutes, and rapid 
recovery upon discontinuation (Krauss & Green, 2006). Children who have received 
minimal sedation (N₂O) may not require more than observation and intermittent 
assessment of their level of sedation during administration (AAPD, 2008). The pediatric 
patient is able to maintain verbal communication throughout the procedure when N₂O is 
used along with the balance of oxygen and without any other sedatives, narcotics, or 
other depressant drugs before or along with the N₂O gas (AAPD, 2008). Nitrous oxide 
administration may be useful in a pediatric oncology setting for sedation in children 
undergoing basic procedures such as a lumbar puncture, bone marrow biopsy and 
aspiration, placing a port-a-cath at the beginning of treatment and removing it at the end 
of treatment, dressing changes, peripheral lab draws, or IV starts if needed. Using nitrous 




time, and helps children experience less anxiety or distress during the procedures (Alai, 
2014). Nitrous oxide use in these situations may create a less traumatic experience for the 
pediatric patient as well as their families.  
Nitrous oxide delivery is not intended to replace any of the current sedation 
methods being used. It would be used to expand the pediatric sedation program by using 
nitrous oxide as an analgesic/anxiolytic. The administration of minimal, moderate, and 
deep sedation is an integral part of pediatric hematology/oncology practice, as well as 
general pediatrics. Procedural sedation is the technique of administering sedatives or 
dissociative agents with or without analgesics to put patients in a state where they are 
able to tolerate painful or unpleasant procedures while continuing to maintain 
cardiorespiratory function (Mace et al., 2008). Creation of a nitrous oxide program can 
increase the child and family’s access to the sedative/analgesic agent (Farrell et al., 
2008).   
Implications for Social Change  
Pain management is an essential nursing and physician responsibility. Physicians 
and nurses are very important aspects of patient and family experience. Pediatric patients 
need to have positive experiences with receiving medical care, as these experiences may 
influence their future feelings about their care and seeking treatment. Adequate pain 
management reduces child and parent anxiety and increases compliance and cooperation 
(Zempsky & Shechter, 2003). Assessment, management, and reassessment of pain are 
part of the Joint Commission standards for pain. Healthcare providers and nursing staff 
need to address the patient’s pain level and if the patient is experiencing pain, appropriate 




understand that some medical procedures can cause pain and distress. They are able to 
assess the pediatric patient’s level pain and anxiety and take action to prevent it, while 
keeping the patient comfortable. It is their role to minimize pain using pharmacologic and 
nonpharmacologic methods to alleviate pain and anxiety related to medical procedures.   
The N₂O program may provide a less traumatic experience for painful and anxiety 
provoking procedures in pediatric patients and provide an additional option for use in the 
pediatric sedation program. Adding the N₂O as a new modality to the pediatric sedation 
program offers a safe method of sedation that provides pain control and anxiety relief 
quickly (Clark & Brunick, 2015). It can be easily reversed if needed by turning off the 
N₂O and delivering 100% oxygen for 3-5 minutes (Clark & Brunick, 2015).  
Definition of Terms 
The terms pertinent to this study are described below. 
Nitrous oxide/oxygen analgesia: Nitrous oxide/oxygen analgesia (also known as 
laughing gas) is an inhalational anesthetic in the form of a colorless and tasteless gas 
containing a mixture of nitrous oxide and oxygen. Nitrous oxide, while practically an 
odorless gas, has a faint, sweet aroma and has analgesic, amnesic, and anxiolytic 
properties (AAPD, 2013; Farrell et al., 2008).  
Levels of Sedation 
Minimal sedation: A drug-induced state during which patients respond normally 
to verbal commands. Although cognitive function and coordination might be impaired, 
ventilatory and cardiovascular functions remain unaffected (American Society of 




Moderate sedation: A drug-induced depression of consciousness during which 
patients respond purposefully to verbal commands, either alone or accompanied by light 
tactile stimulation. Reflex withdrawal from a painful stimulus is not considered a 
purposeful response. No interventions are required to maintain a patent airway, and 
spontaneous ventilation is adequate. Cardiovascular function is usually maintained 
(American Society of Anesthesiologists, 2014).  
Deep sedation: A drug-induced depression of consciousness during which 
patients cannot be easily aroused but respond purposefully following repeated or painful 
stimulation. The ability to independently maintain ventilatory function could be impaired. 
Patients might require assistance in maintaining a patent airway and spontaneous 
ventilation might be inadequate. Cardiovascular function is usually maintained 
(American Society of Anesthesiologists, 2014).  
Procedural sedation: A technique of administering sedatives or dissociative 
agents with or without analgesics to induce a state that allows patients to tolerate 
unpleasant procedures while maintaining cardiorespiratory function (Adams & Dervay, 
2012). 
Additional Definitions 
Anxiolytic: A drug that relieves anxiety. 
Analgesia: A drug that relieves pain.  
Anesthetic: A drug that causes anesthesia.  




Pain: An unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage (International Association 
for the Study of Pain, 2015). 
Anxiety: An emotion characterized by feelings of tension, worried thoughts and 
physical changes (American Psychological Association, 2015).  
Fear: An unpleasant emotion caused by being aware of danger (Merriam-Webster 
Dictionary, n.d).  
Assumptions and Limitations 
Assumptions of the project are that the literature review and secondary data 
provided the necessary information to address the most important indicators for 
developing a N₂O program proposal in the pediatric department and the pediatric 
hematology oncology clinic, since primary data cannot be obtained from the pediatric 
population.  
I developed a comprehensive program proposal for consideration by the pediatric 
sedation team and department leaders. An assumption is that the N₂O program will be 
further developed based on the protocol package presented and that eventually the N₂O 
program will be implemented, though that may take several months beyond my program 
completion to work on a pilot of the program with patient contact; therefore, I will not 
monitor subsequent program elements. A potential limitation of the proposed program 
protocol may be that the supporting documents can take time to be accepted by the 
pediatric sedation team and department leaders. Another possible limitation is that it may 
take longer than expected to complete and/or revise the supporting documents for 





This project focused on developing a comprehensive program proposal for a 
nitrous oxide program for consideration by HSHS St. Vincent Children’s Hospital’s 
decision making committee to expand the pediatric sedation program to include the use 
of N₂O. Nitrous Oxide sedation can be administered for the pediatric population to 
reduce fear, anxiety, and pain response during minor invasive procedures. Nitrous oxide 
in varying concentrations has been successfully used for many years to provide analgesia 
for a variety of painful procedures in children and appears to be well tolerated in the 
pediatric population with no major problems being reported with its use 
(Kanagasundaram et al., 2001; Cravero, 2010; Cote & Wilson, 2008). Research supports 
the safety and efficacy of N₂O in children to reduce fear, anxiety, and pain that are 




Section 2: Review of Scholarly Evidence 
General Literature 
Health care is constantly changing as new evidence and technologies surface that 
support a change in practice. Evidence based practice increases knowledge on new or 
changing health care needs. Nitrous oxide was introduced around 1771 by Sir Joseph 
Priestly (Clark & Brunick, 2015). Nitrous oxide is an inorganic inhalation agent that is 
colorless, odorless (or slightly sweet-smelling), nonirritating to the tissues, and 
nonflammable, though it can be combustible (Becker & Rosenberg, 2008). Nitrous oxide 
is used to provide pain control and anxiety relief and can be reversed very quickly after 
the procedure is completed with oxygen. The popularity of nitrous oxide and nitrous 
oxide/oxygen sedation has varied over the years as some practitioners prefer to use it and 
others do not view it as favorably (Clark & Brunick, 2015). However, N₂O has withstood 
the test of time and is an anxiolytic/analgesic gas option that has never been replaced.  
Numerous studies have shown the benefits and safety of nitrous oxide/oxygen 
analgesia administration for the management of pain and anxiety reduction in children 
undergoing minor surgical outpatient procedures (Annequin et al., 2000; Cleary et al., 
2002; Frampton, Browne, & Lam, 2003; Burnweit et al., 2004; Clark & Brunick, 2015; 
Kanagasundaram et al., 2001; Luhman, Kennedy, Porter, Miller & Jaffe, 2001). 
Researchers have addressed the efficacy, technical aspects, and cost-effectiveness of N₂O 
analgesia (Burnweit et al., 2004; Clark & Brunick, 2015; Kanagasundaram et al., 2001). 
Nitrous oxide has some advantages as compared to other sedation modalities for many 
reasons. First of all, NPO (nothing by mouth) guidelines are not required, intravenous 




escort because of the rapid washout of the gas (Clark & Brunick, 2015). The benefits of 
administering N₂O are the low cost and no hospitalization (Hjortholm, Jaddini, 
Halaburda, & Snarski, 2013). It has a quick induction and recovery because it enters and 
leaves the brain so quickly compared to the other drugs that are given with it (Weaver, 
2013).  
Nitrous oxide was primarily used in dentistry and it is now being brought in as a 
procedural sedation option or for minor surgical procedures. These invasive diagnostic 
and/or minor surgical procedures on pediatric patients occurring outside of the traditional 
operating room setting have increased markedly in the last decade (AAPD, 2002). Over 
the years, procedural sedation and analgesia have grown and have been further advanced 
by new drugs and monitoring technology, expanded practitioner skills, the need to shift 
procedural work to outpatient settings, and widespread acceptance of the ethical 
guidelines to treat pain and anxiety in children (Krauss & Green, 2006).  
When sedation is administered in the pediatric patient, it is usually done to control 
behavior to safely complete the procedure being performed. Pediatric procedural sedation 
is common with pediatric patients due to the painful and anxiety provoking procedures 
that may be a part of their treatment plan. Some of the procedures include lumbar 
punctures, bone marrow biopsies/aspiration, IV starts, wound care, dressing changes, 
urinary catheterization, nasogastric tube placement, and placement of a central line. 
Sedative-analgesic medications can enhance the comfort and acceptance of diagnostic 
and therapeutic procedures in children (Hoffman, Nowakowski, Troshynski, Berens, & 
Weisman, 2002). There is a wide range of short-acting sedative and analgesic 




administration. The choice of drug is based upon the type of procedure, the anticipated 
degree of pain, the targeted depth of sedation, and the patient's underlying medical 
condition (Hoffman et al., 2002). Some procedures are not painful (CT, MRI, radiation, 
bone scans, etc.) can but create anxiety in the child or that the child will need to remain 
still during the test.  Adding nitrous oxide to a procedural sedation program provides 
another method to help reduce pain and anxiety in children.   
Specific Literature  
Painful and Anxiety Provoking Procedures 
Intravenous (IV) Access and Venipuncture. Statistics show that nearly 35 
million people in the United States avoid procedures because of fear and anxiety (Clark 
& Brunick, 2011). Fear of pain can be a major obstacle to overcome, especially in the 
pediatric patient. Children who may require repeated invasive medical procedures have 
anxiety and fear over needles. It can be extreme enough where they develop a needle 
phobia. Fear of needles is very common in the pediatric population and could result in 
poor cooperation from the child. Due to poor cooperation, children may need to be 
restrained during venipuncture, resulting in negative experiences and memories for the 
child and those involved (Williams, Riley, Rayner, & Richardson, 2006; Thurgate & 
Heppell, 2005). An anxiety or fear response can be triggered in children when they are 
exposed to or are anticipating a venipuncture which is often expressed by crying, 
psychomotor agitation, freezing, or clinging to a parent or family member (Thurgate & 
Heppell, 2005).  
Several studies suggest treatments that can be used to alleviate anxiety, fear, and 




(EMLA) cream. EMLA cream is similarly effective in providing pain relief from 
venipunctures in pediatric patients (Paut, Calméjane, Delorme, Lacroix, & Camboulives, 
2001; Hee, Roy, & Ng, 2003). Even with the use of EMLA cream, school-aged children 
would be aware of the needle and could react by showing anxiety due to expected pain 
associated with venipuncture (Hee, Roy, & Ng, 2003).  Application of EMLA cream can 
cause vasoconstriction, which may result in difficulty obtaining IV access (Furuya et al., 
2009; Hee, Roy, & Ng, 2003). Nitrous oxide may be advantageous over EMLA cream in 
reducing pain-related fear and anxiety. Kanagasundaram et al. (2001) and Furuya et al. 
(2009) reported that 50% to 70% N₂O inhalation for three minutes was effective in 
reducing venipuncture pain in children. Carbajal et al. (2008) found that nitrous oxide 
was only slightly better than 2.5% lidocaine/2.5% prilocaine (EMLA) in controlling 
injection pain; however, the combination of the two was significantly better than either 
intervention alone with limited side effects (Abdelkefi et al., 2004). Similar studies also 
showed no difference in pain reduction between nitrous oxide and EMLA cream, but a 
statistically significant synergistic effect was found when combined (Abdelkefi et al., 
2004; Hee, Roy, & Ng, 2003; Paut, Calméjane, Delorme, Lacroix, & Camboulives et al., 
2001). Treatment with N₂O increases the quality of care by facilitating 
venipuncture/venous cannulation without prolonging the effective time and makes it 
possible to complete all procedures and examinations (Ekbom et al., 2005).  
In summary, N₂O has been found to be a safe and effective conscious sedation 
agent for needle sticks across a variety of settings and in a number of different cultural 
groups. The quality of evidence in support of this is quite good overall. Nitrous oxide 




may work better in some instances. In particular, for children with more difficult IV 
access, such as obese clients, N₂O may be more beneficial than EMLA. Distress from 
fear of the mask must be taken into consideration and weighed against the potential 
benefit of greater pain control in younger age groups. A combination of N₂O and EMLA 
has been shown to have a synergistic effect on pain control in several studies.  
Voiding cystourethrograms. A voiding cystourethrogram (VCUG) is a 
radiologic imaging technique that is used in diagnosing and follow-up of a variety of 
childhood diseases, including urinary tract infection (UTI) in children under 1 year of 
age, older children with recurrent UTI, children with ureteric dilatation, terminal 
hematuria accompanied by symptoms of lower urinary tract disease, renal failure of 
undetermined cause, certain voiding problems, thick-walled bladder detected with 
ultrasonography, and infants with significant hydronephrosis detected via ultrasound 
prenatally (Akil et al., 2005). VCUG testing is considered to be an invasive procedure, 
mainly due to the uncomfortable experience of bladder catheterization (Akil et al., 2005). 
Bladder catheterization for radiologic imaging can cause a great deal of psychological 
distress, pain, and anxiety in children (Zier, Kvam, Kurachek, & Finkelstein, 2007; Zier, 
Drake, McCormick, Clinch, & Cornfield, 2007). Several studies suggested oral 
midazolam and 50% inhaled N₂O were comparable treatment methods to reduce pain and 
anxiety associated with bladder catheterization for VCUGs; however, N₂O has an 
excellent safety profile, a more rapid onset, shorter recovery time, and fewer side effects 





In this limited number of studies, N₂O was found to be better at relieving distress 
compared with a control state (Zier et al., 2007), and to be at least as effective as oral 
midazolam for VCUGs (Keidan et al., 2005). Satisfaction data was not statistically 
different between N₂O and oral midazolam, but clinically significant for the individuals 
previously treated with oral midazolam (Farrell et al., 2008). In two studies with a 
relatively large number of combined participants, no serious adverse events were 
recorded with the most common side effect being nausea and vomiting (Zier et al., 2007; 
Zier et al., 2007).  
Miscellaneous painful procedures. Many of the painful procedures described in 
the literature were a combination of medical and nursing procedures, including insertion 
of central venous catheters, facial lacerations, chest tube removal, intra-articular joint 
injections, fiberoptic bronchoscopy, otologic procedures, forearm fracture reductions, 
botulinum toxin A injections, lumbar punctures, bone marrow biopsies, wound care, and 
a wide variety of other procedures performed in an emergency or inpatient care area 
(Abdelkefi et al., 2004; Annequin et al., 2000; Bruce & Franck, 2000; Bruce, Franck, & 
Howard, 2006; Cleary et al., 2002; Fishman, Botzer, Marouani, & DeRowe, 2005; 
Frampton, Browne, & Lam, 2003). The use of N₂O for procedure-related pain control 
was found to be superior in regards to shorter recovery times, greater clinician 
satisfaction, and fewer side effects when compared to moderate, deep, or general 
anesthesia (Burnweit et al., 2004; Cleary et al., 2002; Luhmann, et al., 2001).  
Overwhelmingly, across studies, N₂O was found to be efficacious and safe with 




measured, it was required less often in children sedated with N₂O compared with typical 
rates of restraint (Abdelkefi et al., 2004; Annequin et al., 2000). Abdelkefi et al. (2004), 
Bruce et al., (2006), Cleary et al. (2002), and Fishman et al., (2005) reported low pain 
scores with use of N₂O. Nitrous oxide was found to be significantly more effective than 
standard care in several studies (Fauroux et al., 2004; Luhmann, et al., 2001).  
Administration of N₂O was found to be superior to midazolam (Luhmann et al., 
2001; Zier et al., 2007) and a combination of ketamine and midazolam (Luhmann, 
Schootman, Luhman, & Kennedy, 2006). Mixing N₂O with midazolam did not confer 
any additional benefit, but did increase the risk of adverse effects (Luhmann et al., 2001). 
Nitrous oxide was equally as effective as morphine with a faster recovery time for chest 
drain removal in a small randomized controlled pilot study (Bruce et al., 2006).  A few 
studies reported N₂O to be less effective in younger age groups, usually defined as two to 
three years or younger (Annequin et al., 2000; Fauroux et al., 2004). Frampton et al., 
(2003) stated there were good results in younger children, but no specifics about efficacy 
or safety in this age group were provided.  Kanagasundaram et al., (2001) discuss that 
administration of N₂O for painful procedures in children maintains low distress scores 
during the painful phase and its most appropriate application is for children over the age 
of 6 and for short procedures. 
Adverse Events and Contraindications 
Nitrous oxide/oxygen analgesia use in pediatric procedural sedation is not without 
risks. The American Academy of Pediatrics (AAP) warns that greater than 50% of N₂O 




sedation is decreased when N₂O is used at lower concentrations (below 50%) (American 
Society of Anesthesiologists, 2002; Farrell et al., 2008; Frampton et al., 2003; 
Kanagasundaram, et al., 2001). 
Nausea and vomiting are the most common side effect of N₂O. Administration of 
N₂O does not cause serious side effects (apnea and desaturation below 92%) and the 
incidence of mild adverse events (diaphoresis, nausea, vomiting) are low occurring in 
approximately 0.5-4% of patients (Zier et al., 2007; AAPD, 2013). A higher incidence is 
noted with longer administration of N₂O, fluctuations in nitrous oxide levels, and 
increased concentrations of N₂O (AAPD, 2013). 
Overall, serious adverse events were extremely rare, and generally resolved upon 
discontinuation of the N₂O. One rare adverse event associated with N₂O is inactivation of 
vitamin B12. Nitrous oxide inactivates vitamin B12, inhibits the enzyme methionine 
synthase, and increases plasma total homocysteine with prolonged exposure to N₂O and 
can lead to neuropathy, spinal cord degeneration, and even death in children (Baum, 
Willschke, & Marciniak, 2012; Kanagasundaram et al., 2001). Individuals with 
subclinical vitamin B12 deficiency may be more prone to develop deficits after more 
limited exposure to N₂O (Singer, Lazaridis, Nations, & Wolfe, 2008; Clark & Brunick, 
2015). Patients with B12 deficiency can experience post-procedure effects such as 
myelopathy and neuropathy (Clark & Brunick, 2015).  
Inhaled N₂O provides pain relief, sedation, and alleviation of anxiety 
(Kanagasundaram et al., 2001). Oversedation in one study happened in about 2.9% of 




Oakley, Seaman, Barnett, & Sharwood, 2008). The majority of patients in these studies 
achieved a level of sedation consistent with conscious sedation without loss of verbal 
contact with the child (Babl et al., 2008; Zier, Tarrago, & Liu, 2010). No statistically 
significant differences were found in the incidence of adverse events in children receiving 
< 50% N₂O and those receiving higher percentages (Babl et al., 2008; Zier et al., Liu 
2010). 
Nitrous oxide has an excellent safety profile; however, more children under three 
years of age had a higher risk of reaching deep sedation (Babl et al., 2008), a higher rate 
of adverse events in children less than one year of age (Gall et al., 2001), a higher rate of 
adverse events (Gall et al., 2001), and a deeper level of sedation (Zier et al., 2010) in 
children who had received additional sedation medications. Other studies did not find a 
difference in the rate of adverse events among different age groups (Zier, Tarrago, & Liu, 
2010). Although N₂O has demonstrated an excellent safety profile, providers must be 
prepared for a deeper level of sedation than intended and potential adverse events, 
particularly in the younger age groups and in children receiving concomitant medications.   
Across all studies, major adverse events were quite rare. There were rare reports 
of patients being more deeply sedated than intended (Burton et al., 1998), but these 
episodes resolved without further intervention upon discontinuation of the N₂O. Brief 
desaturations were noted in a few studies (Fauroux et al., 2004; Zier et al., 2007), but all 
resolved without intervention. Common side effects included euphoria, dizziness, 
headache, nausea and vomiting.  
Nitrous oxide is contraindicated in children with bowel obstructions, 




deficiency, cancer therapy using bleomycin, head injuries, inability to understand 
procedure or unwilling to provide consent, and intrathoracic injuries (Clark & Brunick, 
2015). Nitrous oxide use should not be administered for patients with cystic fibrosis or a 
pneumothorax. When N₂O is given in patients with a pneumothorax, the expansive 
quality of the gas causes an increased expansion and size of the pneumothorax (Clark & 
Brunick, 2015). Administration of N₂O should also be avoided in children with cystic 
fibrosis. The expansive nature of the gas may cause bullae. Since nitrous oxide increases 
intracranial pressure by the rapid replacement of nitrogen with N₂O in air spaces, it is 
contraindicated in children with closed head injury and altered intracranial compliance 
(Clark & Brunick, 2015). 
Patient and Parental Response 
Several studies reported a high level of staff satisfaction with N₂O (Abdelkefi et 
al., 2004; Annequin et al., 2000; Luhmann et al., 2001). Annequin et al. (2000) reported 
that 93% of children who were able to answer the question said they would accept N₂O if 
another procedure was to be performed. Satisfaction immediately after and two hours 
after the procedure was higher in the N₂O group in another study (Fauroux et al., 2004). 
Zier et al. (2007) found that parents rated satisfaction with N₂O sedation higher than prior 
sedations with midazolam. In a study by Williams et al., (2006), parents and children 
were highly satisfied when N₂O was used for the procedure. Parents stated that the 
procedure was less stressful, their child did much better with the N₂O, and that they 




made them feel sleepy, they forgot about the procedure, the procedure went very fast, and 
that it had a tingly, light feeling (Williams et al., 2006).  
Distraction and positive incentives are strategies that have become an important 
part of the technique for nitrous oxide administration for procedural sedation. Distraction 
is a great technique that can be used prior to and while administering the N₂O. 
Distraction techniques are used to keep the child calm while wearing the mask which can 
be a source of anxiety. Offering incentives when the child completes the procedure is also 
a great method of distraction as it is something the child looks forward once they are 
finished. Parent variables that may influence the success of parent distraction coaching 
for the child include ethnicity, gender, previous experience, belief about their ability to 
use distraction, anxiety, and parenting style (Kleiber & McCarthy, 2006). Variables may 
affect a child’s response to pain during procedures are age, sex, diagnosis, ethnicity, 
previous experience, temperament, anxiety, coping style, genotype, and ability to pay 
attention. 
There is also relationship between parents’ affective responses before and during 
treatments and children’s responses to the treatment (Harper, Penner, Peterson, Albrecht, 
& Taub, 2012). Penner et al. (2008) found negative associations between parents’ 
empathic concern and children’s pain/distress; meaning, the more empathic concern 
parents experienced prior to treatments, the less pain/distress children were observed to 
experience during the treatments. Children vary greatly in their response to pain. An 
important factor in young children’s reaction to pain is caregiver behavior at the time of 




procedures or treatments without any calming or distracting interventions, but others 
struggle despite any efforts made to help the child stay calm.  
Education  
With all new programs education is a priority. Education should contain evidence-
based practices (EBP) to provide the most current information. Evidence-based practice 
is using the available evidence to make decisions about the care of the patient, and it 
combines information about research results, clinical expertise, patient concerns and 
patient preferences (Johansson, Fogelberg-Dahm, & Wadensten, 2010). The EBP 
information will be used to build on current knowledge. 
Patient education. Benefits of patient education include reducing complications 
of treatment, enhance patient self-confidence, assist the education of health behaviors, 
promote improved function and recovery, elevating patients’ potential to follow a plan of 
care, easing the understanding of their condition, and empowering patients to make their 
health care decisions (Patient Education Institute, 2013). Organization wide benefits 
include complying with regulatory standards, have a greater amount of informed patients, 
elevate customer satisfaction, and increase efficiency with cost-effective care (Patient 
Education Institute, 2013). A well informed, educated patient and/or family member are 
able to actively participate in their own care, improve their outcomes, help identify errors 
before they occur, and reduce the length of stay (Patient Education Institute, 2013). 
Effective patient education can have a large impact on the quality of care given to 
the patient and family, patient safety, and can have improved patient/family satisfaction 
(Tamara-Lis, 2013). For education to be effective it needs to be provided at the literacy 




adults lack sufficient health literacy to completely understand instructions given at, 
during, or after discharge from the hospital or in outpatient healthcare settings (Tamara-
Lis, 2013). Providing a N₂O fact sheet that is easily understood at any health literacy 
level in combination with face-to-face education will help the patient and family member 
understand the use of N₂O, the side effects, and it’s effectiveness for some painful and 
anxiety provoking procedures. Offering educational material will help the patient and 
family make an informed choice about the sedation method they would prefer for their 
child to receive during their procedure.  
Nurse and provider. Education is important because it lays the groundwork and 
allows further advancement in healthcare. Healthcare is a rapidly changing environment. 
Changes in practice require education to properly implement the change. Proper 
education arms the nurses and providers with the knowledge, competency, and skills that 
promote safe and effective high quality care (The Society for Pediatric Sedation, n.d.). 
Staff training is necessary prior to administering N₂O for patient procedures. Governing 
boards and licensing agencies may require specific courses and training in N₂O use 
before providers can use it in their clinical practice settings (Clark & Brunick, 2015). The 
certification program should include didactic education designed to address the 
pharmacology, toxicity, and environmental safety of nitrous oxide as well as the 
equipment used for its delivery (Farrell et al., 2008). Organizations may require three to 
five monitored administrations before the practitioner can administer nitrous oxide on 
their own (Farrell et al., 2008). The pediatric intensivists will be key players in providing 




they will be able to provide education to the staff in the pediatric department and in the 
pediatric hematology/oncology clinic. Education on how to use and set up the equipment 
will be provided by the product vendor. All pediatric staff currently have pediatric 
advanced life support (PALS) certification. The pediatric hematology/oncology and 
PICU staff have completed competencies for administering and monitoring of conscious 
sedation procedures. The PICU nurses and the pediatric hematology/oncology nurses will 
be the primary staff who will monitor the patient during and after administration of N₂O.  
Change Management 
Change is a constant in healthcare. Change management includes planning for, 
managing, and reinforcing change. Change management is the process, tools and 
techniques to manage the people-side of change to achieve the required outcomes (Prosci, 
2015). Change management incorporates the organizational tools that can be utilized to 
help individuals make successful personal transitions resulting in the adoption and 
realization of change (Prosci, 2015). Slack (2011) states, in processing change we must 
identify the problem, agree there is a problem, have support and be able to implement a 
process to make changes. In addition, the involvement of nurses providing effective 
workforce planning, collaboration among necessary colleagues and use of previously 
collected data will gain policy agreement (Institute of Medicine, 2010). 
Designing, implementing, and managing successful change depends on the 
quality of the management team, specifically how the team works to facilitate the change 
process. The key members of the N₂O program will be the executive director, the 
pediatric intensivists, pediatric and PICU department manager, the pediatric 




requires wide range of resources including relational, operational and strategic 
competencies (Yukl, 2006; as cited in Macphee & Suryaprakash, 2012). The N₂O 
program will need to utilize resources from other disciplines to make the program a 
success. The leaders will work closely with anesthesia, biomed, clinical engineering, and 
finance during the program development. 
Change management can be one of the most important and difficult leadership 
responsibilities (Yukl 2006; as cited in Macphee & Suryaprakash, 2012). Leading teams 
into a change process can be difficult. The change project needs involvement of key 
stakeholders and buy-in from the group where the change will be implemented. Without 
buy-in from the staff, there is a high likelihood the change process will fail. 
Organizational readiness for change is essential for implementation of a change to be 
successful. Organizational readiness can be present at the individual, group, unit, 
department, or the organizational levels (Weiner, 2009). 
Leaders can drive change and help an organization cope with the change (White 
& Dudley-Brown, 2012). They also have the ability to influence others and drive 
outcomes. A leader must have a clear understanding of where the organization is today, 
the current health care climate, and the mission and vision of the organization (Elwell & 
Elikofer, 2015). Healthcare leaders must understand the value and critical importance of 
delivering a style of leadership that will ensure that their staff feels empowered and 
supported as they work through and implement changes (Delmatoff & Lazarus, 2014). 
Leaders who do not take into consideration the needs of their staff, the change may be 
met with resistance or confusion. Leaders may encounter many difficulties associated 




success the staff may be more receptive to the change (Delmatoff & Lazarus, 2014). The 
most important traits of a leader involved in change management includes setting goals 
so the team knows what they are working towards; discuss and present desired outcomes 
so the team can brainstorm ideas to gain buy-in (Elwell & Elikofer, 2015); honesty; 
ability to delegate tasks; maintain open communication; have confidence and 
commitment in the team and the work being done; to have a positive attitude; have 
creativity and intuition; and be able to inspire the team.   
Conceptual Models or Frameworks 
The American Academy of Pediatrics and the American Pain Society (2001) list 
the following barriers to treatment of pain in children (p. 793): 
1. The myth that children do not feel pain the way adults do and that there are no 
negative consequences to pain in this age group. 
2. Lack of assessment and reassessment for the presence of pain. 
3. Misunderstanding of how to conceptualize and quantify a subjective 
experience. 
4. Lack of knowledge of pain treatment. 
5. The notion that addressing pain in children takes too much time and effort. 
6. Fears of adverse effects of analgesic medications.  
Because of these barriers, children’s pain often goes undertreated.  
In response to the undertreatment of children’s pain, Huth and Moore (1998) 
proposed a prescriptive theory of acute pain management in infants and children. This 
middle-range theory that was developed from the Acute Pain Management Guidelines 




1. An initial assessment includes concepts of past and present pain history, 
developmental level, coping, and culture. This will lead to the choice of 
appropriate therapeutic interventions. 
2. Therapeutic interventions include child-parent teaching, pharmacologic, and 
non-pharmacologic interventions.  
3. Reassessment consists of regular assessment of pain by child or parent report, 
assessment of behavioral and physiological states, and assessment of side 
effects. Reassessment leads to identification of inadequate pain relief, 
behavioral distress, unacceptable physiological measures, and side effects, all 
of which contribute to the choice of appropriate therapeutic interventions.  
The end result of this model is pain reduction that is satisfactory to child, parent, and 
nurse. This theory has the potential to help nurses ensure that infants and children suffer 
less and avoid the consequences of unmanaged pain (Huth & Moore, 1998). 
This conceptual model can be adapted to incorporate pain and anxiety reduction 
in procedural sedation for children. A thorough initial assessment of previous experiences 
with pain and sedation and consideration of developmental level, individual coping 
strategies, and culture can lead to the selection of therapeutic interventions. In addition to 
child-parent teaching, pharmacologic agents, and non-pharmacologic agents, N₂O could 
be used to help provide pain and anxiety relief for procedural sedation. Regular 
assessment of pain, behavior, physiologic states, and side effects helps to identify 
inadequate pain and anxiety control, leading to the selection of additional therapeutic 
interventions. While N₂O is quite effective, it does not work for everyone or for every 




and anxiety. The end result will be pain and anxiety reduction that is satisfactory to child, 
parent, and nurse. 
 The National Guideline Clearinghouse has developed a guideline titled, 
“Sedation in Children and Young People: Sedation for Diagnostic and Therapeutic 
Procedures in Children and Young People”. The guideline discusses the scope, 
methodology, recommendations, provides evidence for the recommendations, the 
benefits and harms of implementing the guideline, recommendations, and implementation 
of the guideline. The objective of the guideline is to offer best practice advice on the care 
of children and young people under the age of 19 undergoing sedation for diagnostic or 
therapeutic procedures (National Institute for Health and Clinical Excellence, 2010).  
Major recommendations of the guideline include (National Institute for Health and 
Clinical Excellence. (2010): 
• Pre-sedation Assessment, Communication, Patient Information, and Consent. 
o Suitability for sedation. 
o Choosing the most suitable sedation technique. 
o Enabling the child or young person and their parents or care giver to make 
an informed decision, offering them verbal and written information. 
• Fasting prior to procedure. 
• Psychological preparation for the child and their parents. 
• Personnel and training for staff. 
• Clinical environment and monitoring. 




Each of the elements of the National Guideline Clearinghouse will be incorporated in the 
N₂O program proposal package to be presented to the Pediatric Sedation team and the 
department leaders.  
Summary 
The literature summarized here represents a wide variety of pediatric populations 
from across the world; a variety of inpatient, outpatient, and emergency settings; and a 
wide variety of painful or anxiety-provoking procedures. The amount of evidence 
supporting N₂O use is quite good overall, with several randomized controlled trials as 
well as large-scale observational studies demonstrating safety and efficacy. While N₂O 
may not be enough for extremely painful procedures and may provide less benefit 
compared to risk in younger age groups, it has demonstrated a high degree of efficacy 
with a wide safety profile in children. Such an agent has the potential as an intervention 
to improve pain and anxiety management for procedural sedation to assure it is 




Section 3: Approach 
Project Design/Methods 
Once the program protocol package is presented to the pediatric sedation team 
and department leaders, it can be finalized and certain elements such as patient/family 
education materials and the policy and procedure can be branded for the HSHS St. 
Vincent Children’s Hospital. After approval of the program proposal and staff education, 
a pilot study can be performed by the pediatric intensivist and the nurses who monitor the 
patient during administration of nitrous oxide. The proposed pilot test may be performed 
on two groups: children who receive moderate sedation (morphine/versed) and children 
who receive nitrous oxide as an anxiolysis/analgesia agent. The providers will assess and 
select which patients will receive either the N₂O or moderate sedation option and consent 
will be obtained. As part of the proposed pilot study, questionnaires will be distributed to 
each patient/parent(s) to measure how the child fared with the designated method. The 
child and/or parent(s) will be asked to rate their experience with the treatment they 
received and note the child’s level of pain and/or distress with the procedure. The data 
from the surveys will be compiled to determine if N2O administration is an effective and 
safe, comparable option that can be used to reduce assessed and reported pain during the 
particular procedure. The results will be shared with the staff and providers. Pilot study 
and data collection will be performed by pediatric staff and providers once the nitrous 
oxide program has been developed by the staff.   
Population and Sampling  
The population chosen for this project proposal will be pediatric patients admitted 




outpatient pediatric hematology/oncology clinic. Sampling will be data from the RNs, 
LPNs, NPs, MDs, and child life specialists from pediatrics and pediatric 
hematology/oncology.  
Project Team 
In addition to myself, the project team will include pediatric intensivists, the 
executive director, the pediatric/PICU department manager, and the pediatric 
hematology/oncology manager. This will be the core group working on developing the 
program. The core team has been chosen based on their leadership roles in the 
department. The project team will meet on a regular basis (at least monthly) to provide 
updates on the progress of the project and/or delegated tasks. Communications can also 
be done through e-mail and phone conversations. Once the proposal package is 
completed, the I will present it to the project team for necessary changes and feedback. 
Once approved, the departments can begin educate the staff on administration of nitrous 
oxide and begin utilizing it for painful and anxiety provoking procedures.  
Key stakeholders in the process include RN staff (pediatric inpatient, PICU, and 
pediatric hematology/oncology clinic), anesthesia, purchasing, biomedical staff, 
finance/billing, and child life specialists. The patient and parents will also be involved 
once the pilot begins. The stakeholders will be brought into the team meetings when 
appropriate. The comprehensive program proposal will be presented to the team at the 
initial meeting. This will provide valuable feedback for the for me as I finish the program 
proposal. At initial meeting all of the background information and work will be discussed 
with the team and a timeline for developing the program will be created. Stakeholders 




be called upon to provide additional assistance. All members of the team work within the 
organization with the exception of the product vendor. I will facilitate team meetings, 
delegate tasks to appropriate team members, and assist with development of tools 
necessary for the program.   
The department has already received grant money to purchase equipment and has 
planned for the program in the current year’s budget. A product quote will be provided by 
the vendor. The team member from purchasing will be asked to attend a meeting to 
discuss purchasing the products chosen from the vendor. The pediatric 
hematology/oncology clinic was recently renovated and has nitrous oxide piped into the 
procedure rooms that are ready for use.  
Data Collection 
I propose a pilot study when the staff begins to implement the N₂O program. The 
documents created for the DNP project will be used for data collection during the pilot 
study. Data collection will be from staff in the pediatric units and the pediatric 
hematology/oncology clinic. This will be in the form of a needs assessment from the 
RNs, LPNs, NPs, MDs, and child life specialists created in SurveyMonkey and 
disseminated through e-mail that will determine educational needs. The IRB I received 
from the facility will need to be reevaluated to conduct the needs assessment. Data will 
also include the number of moderate sedations using morphine and versed for painful 
procedures. A questionnaire will be developed for the patient/parent(s) for data collection 
before, during, and after the procedure performed to gather information on how they felt 
the N₂O made the procedure tolerable; the effectiveness of N₂O; if they would 




procedures. Staff involved in the procedure using N₂O will also complete a questionnaire 
to include the type of procedure, length of time gas is administered, any complications 
identified, ease of use, patient tolerance, patient pain levels before, during, and after the 
procedure, and if N₂O is recommended for future use.  
The only archival data that may be included is a sedation report that identifies the 
number of sedations performed in pediatrics and in the pediatric hematology/oncology 
clinic. This report can be run by the pediatric intensivist and provided to me. The report 
contains no names and only lists the sedation method used and the procedure performed. 
Another source of data collection would be in the form of reported pain and anxiety. Pain 
assessment is a requirement of the Joint Commission. There are a variety of tools that can 
be used to assess pain and anxiety that are appropriate for the child’s developmental age. 
A variety of tools can also be utilized for measurement of pain. Most are behavioral pain 
scales, acknowledged by some authors as a limitation that makes it difficult to separate 
pain from anxiety (Carbajal et al., 2008). Pain and anxiety are both outcomes of interest 
for this project. The reliability and validity of several of these scales such as the 
Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS) and Observational Scale of 
Behavioral Distress (OSBD) are well-established and are described in systematic reviews 
of such behavioral pain tools (Von Baeyer & Spagrud, 2007; Crellin, Sullivan, Babl, 
O’Sullivan, & Hutchinson, 2007). Often behavioral pain scales are combined with some 
type of visual analog scale rated by children, parents, and/or staff/observers. These scales 
include the numeric pain rating scale (Figure 2); Wong-Baker’s FACES scale, which 




Legs Activity Cry Consolability Scale (FLACC) scale (Figure 4). Satisfaction on the part 




Figure 2. 0-10 Numeric pain rating scale 
 
Figure 3. Wong-Baker FACES® Pain Rating Scale to assess pain in the pediatric patient. 









Figure 4. Faces, legs, activity, cry, consolability (FLACC) pain scale.  
Merkel, S., Voepel-Lewis, T., Shayevitz, J., & Malviya, S. (1997).  
Printed with permission, The Regents of the University of Michigan. 
 
Reliability and Validity of Pain and Anxiety Assessment Tools. The 0-10 
numeric rating scale is widely used to assess pain intensity in the pediatric population. It 
is generally used in children over the age of 8. Patients are asked to rate their pain on a 
scale from 0 to 10, where 0 represents “no pain” and 10 represents “the worst pain 
possible.” Once the patient rates their pain, the nurse will ask the patient what his or her 
goals and expectations are with respect to the pain rating as a measure of satisfaction with 
the current pain relief method (Hartrick, Kovan, & Shapiro, 2003). The numeric pain 
scale has been validated in children 6 years and older and is a clinically meaningful tool 
to guide treatment (Pagé et al., 2012). 
The Wong-Baker FACES scale is a popular method of pain severity assessment in 




spectrum of pain intensity (Garra, et al., 2010). The Wong-Baker FACES scale has 
proven to have content validity and has the potential to be an excellent measure of 
treatment in school-aged children and adolescents (Garra et al., 2010). The FACES pain 
scale is the most psychometrically sound self-report measure of pain in children between 
4 and 12 years of age (Stinson, Kavanagh, Yamada, Gill, & Stevens, 2006; as cited in 
Noel, McCurty, Chambers, & McGrath, 2010). 
The FLACC behavioral pain tool has excellent reliability and validity in assessing 
pain in critically ill adults and children (Voepel-Lewis, Zanotti, Dammeyer, & Merkel, 
2010). The FLACC tool may offer an advantage as it can be used across populations and 
settings, and FLACC scores are comparable to scores obtained by using 0-to-10 number 
rating scales (Voepel-Lewis et al., 2010). 
Data Analysis  
The pilot study will be performed by the pediatric and pediatric 
hematology/oncology staff using the documents I created for the proposal package. Data 
analysis may include the data collected from the needs assessment to help guide staff 
education and determine a general knowledge base of what N₂O is and how it is used for 
painful and anxiety provoking procedures. Results from the staff and patient/family 
questionnaires will also be analyzed by the pediatric and pediatric hematology/oncology 
leaders to identify effectiveness of N₂O use and any recommendations. No new research 
will be done directly on the patients in both pediatric and the pediatric 
hematology/oncology clinic for the project.  
A satisfaction survey that I created will be used by the staff to determine 




being performed. Satisfaction data will be recorded from the patient and parental 
experience of receiving N₂O for painful procedures, fear of the procedure, and anxiety 
related to the procedure. Children will be able to rate their satisfaction with the pain and 
anxiety management when explained to them in a developmentally appropriate way. 
Additionally, parents and the sedation nurse will also be asked to rate their satisfaction 
with pain and anxiety management of the child before, during, and after the procedure. 
This data will be used to provide additional information of the overall effect of the 
intervention.    
Project Evaluation Plan 
Process evaluation for this project will include the following: 
1. Documentation of IRB approval from the Walden University and HSHS St. 
Vincent Children’s Hospital. 
2. Development of needs assessment from the RNs, LPNs, NPs, MDs, and Child 
Life Specialists to be disseminated by the pediatric and pediatric 
hematology/oncology leaders. 
3. Determination of scope of practice (RN delivery versus MD delivery). 
4. Obtaining a quote and purchasing equipment needed to deliver nitrous oxide. 
5. Development of proposed policies and procedures, documentation on the 
sedation record and sedation navigator in Epic, fasting protocol, and parent 
education brochure, RN and Parent procedure surveys. 
6. Determine what education is required for staff and providers. 




There are many processes that can help to evaluate the outcomes to determine if 
they have been met or need to be adjusted to meet the objectives. Research states that 
recovery from N2O is approximately 5-10 minutes after the gas has been stopped and the 
patient is ready for discharge within 30 minutes after (Clark & Brunick, 2015). Moderate 
sedation requires a minimum of a one hour recovery which could take longer depending 
on the patient (J. Taylor, personal communication, August 3, 2015). Once nitrous use is 
implemented, length of stay can be tested and compared to that of moderate sedation.  
Nitrous oxide administration may be useful in a pediatric oncology setting for 
sedation in children undergoing basic procedures such as a lumbar puncture, bone 
marrow biopsy and aspiration, placing a port-a-cath at the beginning of treatment and 
removing it at the end of treatment, dressing changes, or IV starts if needed. Nitrous 
oxide provides for an almost pain and anxiety-free procedure, requires neither an 
intravenous line nor post-procedure monitoring, and minimizes any unpleasant memories 
the child may have (Burnweit et al., 2004). To evaluate this outcome, a survey would be 
completed by the patient and/or parent for satisfaction and if the N2O was effective in 
reducing pain, anxiety, and/or fear during the procedure. Other evaluation criteria may 
include the type of patient and indication for N2O use, success of treatment, and behavior 
of the patient during the procedure, and any adverse effects noted (Collado et al., 2008). 
 The proposal package will include tools used to assist in developing new practice 
guidelines would include how the physician will assess whether or not the patient is a 
candidate to receive N2O as well as consent; a monitoring tool for the sedation nurse to 
use during the procedure for documentation of vital signs, O₂ saturation, pain scores, and 




patient/parent survey will be created to evaluate N2O use as compared to moderate 
sedation using versed and morphine.  
Since this is a brand new program, there are many elements that have to be 
developed such as a hospital policy, assessment tools (hard copy or in electronic medical 
record), guidelines, education, and staff/parent surveys. Along with implementing the use 
of N2O, there will also be a need for patient and family education; therefore, if their child 
is a candidate, they are able to make an educated decision regarding which therapy they 
would like their child to receive. A parent education pamphlet will be developed to give 
to the parents when the procedure is scheduled so they understand what N₂O is, side 
effects related to the gas, how it is used, and information regarding its effectiveness and 
safety.   
Proposal Package Documents 
The proposal package for the N₂O program will include several components such 
as a proposed policy and procedure; changes to the sedation record to include nitrous 
oxide delivery that will be added to the Epic sedation navigator; proposed needs 
assessment for education and knowledge base of staff; RN and patient/family procedure 
surveys; sample MD order set; where providers will obtain education and who will be 
deemed a champion to education staff in the departments; fasting guidelines; and 
patient/family education materials. These documents will be presented to the pediatric 
leaders as part of the completion of the DNP project. Evidence-based research will be 
used to create the program proposal to provide the most current information regarding the 





It should be noted that N₂O may not be effective or necessary for every child. 
Appropriate assessment should lead to the choice of effective pain management 
strategies. Some children may need pharmacologic intervention beyond N₂O and topical 
anesthetics to effectively manage distress. Providing a comprehensive program protocol 
package will assist in planning a successful project that meets the needs of the pediatric 




Section 4: Findings, Discussion, Implications 
Introduction 
The purpose of this project was to assess the need and gather support for 
development of a comprehensive program proposal for a nitrous oxide program in 
pediatrics. Nitrous oxide provides analgesia and anxiolysis. Administration of N₂O for 
procedures causing pain, fear, and/or anxiety allows for better cooperation from the 
pediatric patient for adequate completion of the procedure. Nitrous oxide has an excellent 
safety record and provides pain control and anxiety relief that is quickly and easily 
reversed (Clark & Brunick, 2015). The child remains calm and maintains verbal contact 
with the administering provider during the procedure.  
The goal of the project was to develop a program proposal for a N₂O sedation 
program for the pediatric team to use during their development and implementation of the 
program. The N₂O program will be used to minimize pain and anxiety associated with 
some medical procedures. Children admitted to the pediatric department as well as the 
pediatric hematology/oncology clinic often go through procedures such as IV starts, 
urinary catheterization, lumbar punctures, bone marrow aspirations, central line 
insertions, port-a-cath access, nasogastric tube insertions, or gastrostomy tube changes. 
Each of these procedures can be pain, fear, or anxiety provoking. The goal of the nitrous 
oxide program is to minimize pain, fear, and anxiety associated with those procedures, 
which allows for completion of the procedure.  
Discussion of Project Products 
The scholarly products developed for the nitrous oxide protocol included a 




documentation in the Epic Sedation Narrator to include nitrous oxide; a proposed needs 
assessment for education and knowledge base of staff; RN and patient/family procedure 
surveys; sample MD order set; education staff plan; fasting guidelines; patient/family 
education materials; and obtaining a quote for equipment. The scholarly products were 
presented to the pediatric leaders for review and approval. 
Concept Map.  
To begin the planning phase of the project, a concept map was created (Appendix 
A). Brainstorming ideas at the beginning of the project was valuable in determining what 
products would be necessary to present to the pediatric leaders to aid in their 
development and implementation of the nitrous oxide program in the inpatient 
departments and the pediatric hematology/oncology clinic. A concept map is a tool that 
shows the main idea, subconcepts, and cross-links and organizes the relationships 
between concepts (Noonan, 2011). The concept map included the stakeholders, safety, 
education, policy, scope of practice, finance, equipment, tools, regulatory issues, patient 
population, and the physician group. Each of these subconcepts is critical to planning a 
successful program.  
Policy and procedure. As part of the program protocol package, a proposed 
nitrous oxide policy and procedure (Appendix B) was developed using current evidence-
based practice. This policy was presented to the pediatric leaders for feedback to include 
revisions and approval of the policy to continue on in the process for approval by the 
organization. The pediatric medical director was a key stakeholder in developing the 




Sample MD order set. The proposed physician order set included the 
concentration of N₂O/O₂ to initiate the procedure, the continued concentration 
throughout the procedure, the order to administer 100% O₂ for 3-5 minutes after 
discontinuing N₂O upon completion of the procedure, and a discharge order. An example 
of a physician order set can be found in Appendix C. The pediatric medical director has 
chosen to use the sample order set as a guide to developing the orders for N₂O 
administration. Another option may be to add N₂O to the existing procedural sedation 
order set.  
Fasting guidelines. The pediatric sedation program has defined the fasting 
guidelines as nothing by mouth (NPO) for solids after midnight, clear liquids until 2 
hours prior to the procedure, and then NPO. The guidelines will remain in place for 
planned procedures using N₂O. For unplanned procedures such as IV starts, difficult 
port-a-cath access, or lab draws, the physician may waive the fasting guidelines. The 
physician will ask the patient prior to administering N₂O what they ate or drank prior to 
the procedure. Typically, patients may eat a light meal no closer than 2 hours prior to the 
procedure (Clark & Brunick, 2015).   
Sedation record. Documentation of a procedure of nitrous oxide will include the 
concentration of N₂O/O₂ administered; the start and stop times of the N₂O; vital signs 
every 5 minutes during the procedure; an Aldrete score preprocedure, postprocedure and 
every 15 minutes until the patient is fully recovered and back to baseline activity; ASA 
level documented in the physician’s dictation note; and a Richmond Agitation and 
Sedation Scale (RASS) score during the procedure. The procedural sedation record was 




Proposed needs assessment/education plan. The proposed needs assessment 
may be used by the pediatric leaders during the development of the N₂O program to 
assess the knowledge base of the pediatric staff members (Appendix E). The data 
collected from the needs assessment may be used to guide staff education. The same 
needs assessment can be used after education to assess knowledge gained through 
education.  
The proposed education plan is for a select group of staff to attend a didactic and 
hands-on education course offered by American Family Children’s Hospital in Madison, 
Wisconsin. The course provided is taught by the assistant professor of pediatrics who is 
also the associate director of pediatric sedation. The group selected may include two of 
the pediatric intensivists, the managers of pediatric and pediatric hematology/oncology, 
child life specialists, a PICU RN, and a pediatric hematology/oncology RN. The pediatric 
intensivists will then be responsible for staff education in the departments.  
The equipment vender will also be sending a clinical product specialist to do 
education on the Porter Sentry Sedate N₂O system. There will be six sessions over 2 days 
that are approximately one hour in length. There will also be a 15 minute video to show 
how to set up, use, and break down the equipment. 
RN/family survey. Once the pediatric department and the pediatric 
hematology/oncology clinic begin the pilot program, surveys can be used to assess the 
level of pain, distress, and anxiety the patient has before, during, and after the procedure 
where N₂O is administered. The survey of the RN staff will be used to determine 
satisfaction of N₂O for the procedure (Appendix F). The parent survey will be used to 




will be used to assess the effectiveness of N₂O sedation from both the RN staff and the 
parent.  
Patient and family education. Education is very important in any new program. 
Nitrous oxide sedation is a new concept and the patient and family will need education 
prior to choosing it for their child’s procedure. Education materials developed for the 
program proposal includes a N₂O fact sheet (Appendix H) and an educational brochure 
(Appendix I). Information in the educational materials includes what N₂O is, how it will 
help the child during the procedure, how it is given, what the risks are, what the parent 
can do to help the child, and the role of the child life specialist.  
Equipment quote. Grant money will be used to purchase the equipment 
necessary to deliver N₂O to the pediatric patient. The quote for the equipment was 
received and the department is planning to purchase the equipment in June, 2016 
(Appendix J).  
Implementation Plan 
The products completed for the N₂O sedation program can be used by the 
pediatric leadership team to develop and implement the program in the pediatric 
departments. The leadership team can continue with development of the program by 
seeking hospital approval of the policy and procedure and then begin scheduling 
education for the pediatric intensivists as well as a select group of nursing staff. These 
individuals will be key members to provide education to the staff in pediatrics/PICU and 
the pediatric hematology/oncology outpatient clinic. The vendor will also be responsible 
for education on the set-up and break down of equipment. Once the N₂O program has 




team can begin a pilot and collect data on the procedures using N₂O sedation. Data can 
be used to determine efficiency and satisfaction with N₂O use for medical procedures. 
Implications 
The program proposal for a N₂O sedation program in the pediatric/PICU inpatient 
departments and the pediatric hematology/oncology outpatient clinic included a hospital 
policy and procedure. The policy was presented to the pediatric leaders as well as the 
pediatric medical director for feedback and potential approval of the policy. The pediatric 
medical director was instrumental in developing the policy. The medical director has 
many years of experience in developing policies and is an expert in his field of medicine. 
The feedback received on the first draft of the policy helped to revise the content to create 
a solid policy for administering N₂O to the pediatric patient.  
This project may pave the way for the pediatric staff to utilize a minimal sedation 
method that will minimize pain, fear, and anxiety associated with some medical 
procedures. The short acting and rapid recovery of N₂O can satisfy the needs of patient 
and family. Parents do not like to see their children in distress. Those situations causing 
pain, fear, and anxiety can set a negative tone for the child’s hospitalization and 
potentially cause more trauma.  
Strengths 
A strength of the project was the effective interprofessional collaboration. An 
advantage in the development of this project group was that most of the individuals 
already worked closely together with a high degree of multidisciplinary collaboration. 
Adding a N₂O sedation to the pediatric sedation program was well received by the 




and anxiety associated to medical procedures is a priority in providing the very best care 
to the pediatric patient. The multidisciplinary team valued and respected each member’s 
input, which contributed to excellent interprofessional collaboration and enthusiasm for 
this project.  
Limitations 
An anticipated limitation of the proposed program was involvement of the 
anesthesia department. This project involved is one of the first programs to use an 
inhalation agent outside of the operating room within the institution; it was believed that 
this could be seen as a “turf” issue with anesthesia. Input from the anesthesia department 
was needed for many aspects of the project. According to Rose (2011), sharing such 
disciplinary expertise can be perceived as threatening to an individual when that 
knowledge would enable other professionals to take on aspects of that individual’s own 
role. Because of the deeper understanding of children and their unique pain and sedation 
needs, the director of anesthesia was approached for assistance with the N₂O program. 
When members of the project team explained what the goals of the project were, the 
anesthesiologists were very supportive of the program. By involving the anesthesia 
department in the program proposal, they we able to maintain some control of their 
identity and territory within this project. 
Another limitation of the project was maintaining a meeting schedule with the key 
stakeholders in the project. Each of the individuals had very busy schedules and 
coordinating a time that worked for all of them was very difficult and it was rare that the 
team was able to sit down together to review the proposal of the program. Much of the 




group meeting. A plan for future projects would include planning regular meetings ahead 
of time to ensure the multidisciplinary team can meet as a whole group rather than 
individually as time permits. The meeting times would then be on the team members’ 
schedule for better attendance and commitment to the project.  
Analysis of Self  
The past 18 months of doctoral education has expanded my engagement in a 
higher level of academic activities which include program planning and development. 
Prior to the doctoral education, I had minimal experience in these types of leadership 
activities. New knowledge about leadership responsibilities and activities necessary for 
change has been instrumental in improving confidence in leadership skills. Improved 
leadership skills will assist in future planning, organizing, and facilitating program 
development. Learning how to appropriately plan, implement, disseminate, and evaluate 
a program allows me to become more successful with future projects and job 
responsibilities as a leader.  
Developing a program proposal for administration of N₂O in the pediatric patient 
has been a very valuable learning experience. Leading a multidisciplinary team in 
successful planning of the project was not without challenges. However, the whole team 
was able to come together to approve the proposal of the program. Using the products 
developed in the DNP project, the team can move forward with developing the N₂O 
program in the pediatric/PICU departments and the pediatric hematology/oncology clinic 
to provide the pediatric patients with a sedation method to minimize pain, fear, and 




organization that serve pediatric patients such as radiology, GI lab, and the emergency 
department.  
As a Scholar 
The AACN (1999) defines scholarship as “activities that systematically advance 
the teaching, research, and practice of nursing through rigorous inquiry that 1) is 
significant to the profession, 2) is creative, 3) can be documented, 4) can be replicated or 
elaborated, and 5) can be peer-reviewed through various methods” (para. 1). This project 
provided me with the opportunity to develop skills through building an evidence-based 
program proposal for a N₂O program in the pediatric/PICU departments and the pediatric 
hematology/oncology clinic. Development of the policy, education plan, staff and family 
education, documentation to include N₂O for sedated procedures, staff and family 
surveys to present to the pediatric leaders was a valuable experience. Preparation of the 
program proposal provided me with the ability to comprehend, appraise, and interpret the 
literature surrounding the safety and efficacy of N₂O administration in pediatric patients. 
Through gaining an understanding of the literature surrounding N₂O I was able to apply 
the most current evidence-based information into creating the comprehensive program 
proposal to present to the pediatric leadership team for approval.  
As a Practitioner 
The doctorate preparation has provided me with better understanding of the 
leadership role. Leaders are effective in facilitating change. The N₂O program is a new 
program that will be implemented in the pediatric practice areas. Change is not always 
well received; however, this was not the case for this project. During the preparation of 




the N₂O program. The knowledge and skills learned at the doctoral level have allowed 
me to achieve the outcomes of the project, develop a program proposal, and present it to 
leaders to use for development of the N₂O sedation program. Plans are in place by the 
pediatric leaders to use the proposed program prepared by through DNP project to 
develop and implement the N₂O program by August 2016.  
As a Project Developer 
The experience of developing N₂O program offered me the opportunity to 
identify an evidence-based project in the pediatric department at HSHS St. Vincent 
Children’s Hospital. Experiences included working together with a multidisciplinary 
team to develop a program proposal of a new sedation method to minimize pain, fear, and 
anxiety in pediatric patients undergoing medical procedures, developing a comprehensive 
policy for administering N₂O, preparing patient, family, and staff education. Presenting 
the program proposal to the pediatric leadership team has given me improved confidence 
for future program development opportunities.  
Summary  
According to Taddio et al. (2009), pain relief is a basic human right, and reducing 
procedural pain in children demands prioritization by healthcare agencies, researchers, 
and parents. Safe methods to alleviate such pain are readily available and N₂O is one 
more method that can be used for pediatric patients. Greater distress during such 
procedures leads to more negative memories, which can have serious effects on 
compliance of treatment. Patients may avoid receiving necessary healthcare due to pain, 




During this project, it has become clear that changing the culture to add N₂O has 
been well received by the pediatric leadership team and staff in the departments. 
Enthusiasm for the eventual implementation of N₂O program has spread throughout the 
pediatric departments and the staff members are looking forward to using it for future 
procedures. The pediatric leadership team may be utilizing the tools and resources 
created from this project to develop and implement the N₂O program.  
Culture change takes time, but with better education of healthcare professionals 
on the importance and ethics of pediatric pain management, interventions like nitrous 
oxide could become the norm. Taddio et al. (2009), discussed that suboptimal 
implementation of comprehensive pain management programs can be attributed to a lack 
of knowledge about pain and effective pain prevention strategies, as well as the 
persistence of attitudes and beliefs about pain that impede clinical progress in this area. 
Projects such as this can educate and change the attitudes of healthcare providers so that 




Section 5: Scholarly Product 
Introduction 
The proposal of a comprehensive N₂O program for pediatrics was presented to 
the pediatric leadership team on March 21, 2016. The leaders were able to review the 
proposal and provide feedback. The policy and procedure was revised and returned to the 
pediatric medical director on March 28, 2016. The products of the proposal were 
approved by the pediatric leadership team and may be used for the future development of 
the N₂O program in pediatrics, PICU, and pediatric hematology/oncology clinic.  
Problem 
Pain in the pediatric patient is often undermanaged. Pain, fear, and anxiety can be 
associated to some medical procedures. Examples of routine procedures that cause these 
emotions include IV starts, lab draws, port-a-cath access, lumbar puncture, and urinary 
catheterization. Distress and anxiety can enhance the child’s perception pf pain 
(Rodriguez, et al., 2012). Nitrous oxide is used to induce minimal sedation for these 
routine procedures to help alleviate pain, fear, and anxiety in the pediatric patient.  
Purpose  
The purpose of the DNP project was to create a comprehensive N₂O program 
proposal to present to the pediatric leadership team to move forward with their 
development of the N₂O sedation program. According to the executive director of 
pediatrics, adding a N₂O program was something the leaders and pediatric intensivists 
have talked about since 2013. The program proposal developed through the DNP project 






The goals and outcomes of the DNP project were met by developing a 
comprehensive proposal of the N₂O program for pediatrics and presenting it to the 
pediatric leadership team. Patient and family education materials were developed to 
provide information on N₂O, which was also presented. The HSHS St. Vincent 
Children’s Hospital is going through the planning process and has not selected a graphic 
icon to represent the hospital. Once the icon is chosen, the education materials can be 
submitted to the organization for approval and branding. After the proposal was 
presented to the pediatric leadership team, there was positive feedback; however, some of 
the components needed revisions or modifications. The requested changes were made and 
presented to the team a second time at which time they approved the materials and 
allowed me to proceed with portions of the proposal that the organization needed to 
approve. The procedural sedation record was approved by health information 
management and was loaded into Epic forms for staff to utilize. There has been a request 
to add N₂O to the Epic Sedation Narrator for documentation of the administration and 
concentration of N₂O used for the procedure. The policy and procedure will be moving 
forward to seek approval from the anesthesia department and then approval from the 
organization.  
Significance to Practice 
The products created for the N₂O sedation program may be used to assist in 
further development and eventual implementation of the program. Nitrous oxide sedation 
provides a minimal sedation option for the pediatric procedural sedation program. Nitrous 




the child’s pain, fear, and anxiety that may be associated with some medical procedures. 
Both pain and anxiety are managed with N₂O to help the child remain calm in order to 
facilitate completion of the procedure. The minimal sedation technique can reduce the 
need for restraining the child to complete the procedure and can minimize the number of 
needle stick for IV starts, port-a-cath access, and/or lab draws.  
Literature and Evidence to Support Project 
A systematic literature review was conducted using the simultaneous 
CINAHL/MEDLINE database with combinations of keywords including pain, anxiety, 
fear, pediatric, nitrous oxide, child, developmental ages, intravenous catheterization, 
urinary catheterization, sedation, and conscious sedation. Literature from the systematic 
review showed N₂O sedation having an excellent safety profile and that it can be 
effectively used to minimize pain, fear, and anxiety in children due to routine medical 
procedures. Nitrous oxide has anxiolytic, analgesic, and amnesic properties to help 
manage pain and keep the child calm during the procedure being performed.  
Frameworks 
Frameworks used for the DNP project include Huth and Moore’s prescriptive 
theory of acute pain in children and the National Guideline Clearinghouse guideline for 
sedation in children and young people. Both frameworks discuss pain control in the 
pediatric patient. Minimizing pain, fear, and anxiety during hospital admissions and clinic 
visits is a priority in managing care in the pediatric patient. The frameworks discussed in 
the project were incorporated when developing the products for the proposal of a N₂O 




used to reduce pain, fear, and anxiety for routine medical procedures and procedural 
sedation. 
Summary 
Input received and integrated from key stakeholders contributed to the success of 
this project. Their feedback was a valuable asset while creating the program proposal for 
a nitrous oxide program in pediatrics. The nitrous oxide program proposal was created to 
provide a minimal sedation option to add to the current pediatric sedation program. 
Managing procedural pain and anxiety in the pediatric patient is a top priority. Nitrous 
oxide has an excellent safety profile and will be used to minimize procedural pain, fear, 
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Appendix B: Proposed Policy and Procedure for N₂O Administration 
 
SUBJECT:  Administration of Nitrous Oxide          Effective Date:  
                Next Revision Due:  
  
AREA: Pediatrics, PICU, Pediatric Hematology/Oncology 
 










POLICY: Nitrous oxide use to produce minimal sedation for medical procedures in 
Pediatrics, PICU, and Pediatric Hematology/Oncology. 
PURPOSE: To provide guidelines for pediatric patient management of all procedures 
requiring the use of nitrous oxide sedation by non-anesthesia personnel. 
PROCEDURE: 
I. Procedure: 
A. Indications for use: 
1. Nitrous oxide may be used as a minimal sedation agent for 
procedures that may cause pain or anxiety, including but not 
limited to: 
a. Insertion of intravenous catheter/port-a-cath access 
b. PICC line insertion 
c. Lumbar Puncture 
d. Insertion of urinary catheters 
e. Nasogastric tube insertion 
f. Injections 
g. Painful dressing changes 
h. Gastrointestinal tube changes 
i. Other minor procedures (MRI, CT, Nuclear Medicine, etc.) 
B. Contraindications 
1. Nitrous oxide will diffuse into a closed space or fluid filled space 
and expand air, causing increased pressure within the closed 
space. Nitrous oxide may also slightly increase intracranial 
pressure. The potential for teratogenicity and abuse exists.  
a. Pneumothorax/Pneumomediastinum 




c. Recent middle ear occlusion or tympanoplasty 
d. Pulmonary bullae or severe bullous emphysema (e.g. 
caution with cystic fibrosis) 
e. Air embolism 
f. Decompression sickness 
g. Maxillofacial injuries with potential for trapped gas 
h. Intraocular surgery, penetrating injury to the globe, or 
increased intraocular pressure (past 10 weeks) 
i. Recent myringoplasty 
j. Pneumocephalus 
k. Within 3 weeks following a craniotomy 
l. Increased intracranial pressure 
m. Pregnancy 
n. Vitamin B12 deficiency 
o. Impaired level of consciousness 
p. History of bleomycin administration 
q. Intoxication with drugs or alcohol 
r. Current or recovering drug addiction 
C. Qualifications of administering provider: 
1. To administer nitrous oxide, providers must complete a nitrous 
oxide training course. Training includes didactic component and 
monitored hands-on training to include 3 supervised nitrous 
oxide administrations with an experienced mentor to establish 
competency. 
2. The administering provider must be qualified to recover the 
patient from a level of sedation beyond that intended. 
D. Qualifications of monitoring RN: 
1. Nitrous oxide may only be ordered and administered by a 
medical provider specifically credentialed by the Medical Staff 
in the administration of nitrous oxide as a minimal sedation 
agent. 
2. PALS certification required and established competency in 
monitoring sedations 
3. Pregnant staff in the first trimester must not participate in nitrous 
oxide administration. 
II. Equipment 
A. Storage of equipment and Nitrous Oxide tanks must be in a designated 
locked area. 
B. Replacement tanks will come from the Storeroom 
C. Equipment check performed prior to sedation.  
1. Oxygen and nitrous oxide tubings connected to appropriate 
tanks. 




3. Nitrous Oxide auto-cutoff test: Start a minimal flow of nitrous 
oxide; turn off oxygen flow and be sure nitrous oxide flow also 
stops. 
4. Confirm the absence of leaks at pressure connections. 
5. Scavenging equipment intact and prepared to operate during 
nitrous oxide administration  
III. Nitrous Oxide Pre-Anesthesia Assessment: 
A. Current medical history including medications and allergies 
B. Past medical history to include past anesthetic history to include 
problems with anesthesia or sedation 
C. Focused physical exam to include: 
1. VS and weight 
2. Malampati Score 
3. Heart  
4. Lungs 
5. ASA Status 
D. NPO Status 
1. Follow sedation NPO guidelines located in policy #100-22-001: 
Procedural Sedation (Appendix 6). 
2. NPO guidelines may be waived by the medical staff provider in 
special circumstances. 
E. Patient/Family Preparation 
1. Educate patient, parent, and/or legal guardian regarding nitrous 
oxide administration. 
2. Use of topical anesthetic for IV starts is recommended even if 
nitrous oxide is used. 
3. Involve Child Life Specialists with procedure preparations to 
alleviate anxiety associated with procedure and mask. 
F. Obtain informed consent 
G. Perform Time Out and complete Time Out Checklist: 
1. Patient correctly identified for procedure using two identifiers. 
2. Patient evaluated for presence of contraindications to use of 
nitrous oxide 
3. Confirm that orders call for no less than 30% oxygen whenever 
nitrous oxide is administered. 
4. Emergency equipment available at bedside as per Policy #100-
22-001: Procedural Sedation (Appendix 3). 
IV. Intra-procedure Monitoring 
1. Documentation of nitrous oxide concentration, pulse oximetry 
value, and level of sedation will be recorded at the onset of 
administration, with any changes in administered nitrous oxide 
concentration, and every 5 minutes thereafter on the patient 
record. 
2. In addition to level of sedation and nitrous oxide concentration, 




pulse oximetry will be monitored every 5 minutes until patient 
returns to pre-sedation baseline, at which point VS may be 
discontinued.  
3. Continuous direct observation by a qualified RN is mandatory 
throughout nitrous oxide administration. 
V. Post-procedure Monitoring 
1. Stop flow of nitrous oxide and administer 100% oxygen post 
procedure for 5 minutes to flush nitrous oxide from the patient’s 
system and to avoid risk of diffusion hypoxia. 
2. Pulse oximetry levels will be recorded until recovery is 
complete. 
3. Monitor for nausea and vomiting 
4. Adverse event such as emesis, vasovagal reaction, seizure, 
anaphylaxis or anaphylactoid reaction, cardiopulmonary 
impairment, or depth of sedation deeper than that intended, 
during the sedation period as well as interventions required will 
be documented. 
5. May discharge per physician order once patient meets discharge 
criteria refer to Policy #100-22-001: Procedural Sedation. 
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Appendix C: Proposed Physician Orders for N₂O Administration 
 




Attending Physician: ______________________________ 
Weight: _________________________________________ 
 
Please CHECK desired orders. 
 
_____ 1. Complete nitrous oxide time out prior to initiation of sedation.  
 
_____ 2. Initiate nitrous oxide at _____% (maximum 70%) x______ minutes.   
 
_____ 3. Continue administration at _____% to _____% (maximum 70%) for duration of 
   procedure (maximum ______ minutes). 
 
_____ 4. Upon discontinuation of nitrous oxide, administer 100% FiO2 x 5 minutes to 
prevent   
  diffusion hypoxia. 
 
 






Appendix D: Procedural Sedation Record 
 














Appendix F: RN Satisfaction Survey 
Patient Pain Assessment Data Collection Form during Nitrous Oxide Administration 
 
Gender:  □ Male  □ Female Date of Procedure: _____/_____/_____ 
Diagnosis: 
Procedure:   
 
Pain Assessment before Sedation: Patient Response 
 
Nurse Completes FLACC (if child <3 years old) 
 
Nurse Asks Child FACES Pain 
Rating (if child ≥3) 
 
0-10 scale (for children <6) 
 
 
Nurse’s Assessment of Patient’s Pain No Pain                                     Worst Pain  
                                                        Possible                                  
  0     1    2    3    4    5    6    7    8    9    10 
 
Pain Assessment during Procedure: Patient Response 
Nurse Completes FLACC (if child <3 years 
old) 
Nurse Asks Child FACES Pain Rating 







0-10 scale (for children <6) 
 
 
Nurse’s Assessment pf Patient’s Pain No Pain                                                                   Worst Pain 
                                                                                   Possible 
                                                                   
  0    1    2    3    4    5    6    7    8    9    10 
 
After Procedure (Prior to Discharge) 
Nurse Completes FLACC (if child <3 years 
old) 
 
Nurse Asks Child FACES Pain Rating 
(if child ≥3) 
 
 
0-10 scale (for children <6) 
 
 
Nurse’s Assessment pf Patient’s Pain No Pain                                     Worst Pain  
                                              Possible                                                 
  0     1    2    3    4    5    6    7    8    9    10 
Nurse’s Estimate of Ease of 
Procedure 
□ Easy 
No Issues  
□ Difficult  
Patient movement or 
resistance 
□ Very Difficult 
Patient movement or 
resistance, traumatic 
procedure 
Nurse Ask Patient Can you tell me about your visit today? 
 




Interventions (check all that 
apply) 
□ Distraction (videos, music, etc.) 





Appendix G: Parent Satisfaction Survey 
 
Form Completed By:  □ Mother    □ Father   □ Other Guardian, specify:__________________  
Type of Procedure:_________________________________________ 
 




Estimate your child’s pain No Pain                                                                     Worst Pain  
                                                                                     Possible 
  0      1    2    3    4    5    6    7    8    9    10 
Estimate your child’s distress No Distress                                                               Worst Distress  
                                                                                        Possible 
  0      1    2    3    4    5    6    7    8    9    10 
 
During Procedure 
Estimate your child’s pain No Pain                                                                     Worst Pain  
                                                                                     Possible 
  0     1     2    3    4    5    6    7    8    9    10 
Estimate your child’s distress No Distress                                                               Worst Distress 
                                                                                        Possible 
  0     1     2    3    4    5    6    7    8    9    10 
 
After Procedure (before you leave the clinic) 
Estimate your child’s pain No Pain                                                               Worst Pain                                                                                
                                                                              Possible 
  0     1    2    3    4    5    6    7    8    9     10 
Estimate your child’s distress No Distress                                                         Worst Distress                                                                                 
                                                                                Possible 
  0     1    2    3    4    5    6    7    8    9     10 
Your Satisfaction with the sedation 
provided for this procedure 
Extremely                                                                    Extremely 
Satisfied                                                                Dissatisfied                                                
  0     1    2    3     4    5    6    7    8    9     10 
Your child’s satisfaction with sedation 
provided for this procedure 
Extremely                                                             Extremely                                                                 
Satisfied                                                              Dissatisfied                                                
  0     1    2    3     4    5    6    7    8    9     10 
Did your child have any problems with 
the procedure? Check all that apply. 
Nausea                             □ Yes   □ No 
Vomiting                           □ Yes   □ No 
Combative behavior                  □ Yes   □ No 
Unstableness when leaving for home     □ Yes   □ No 
Was your child able to return back to 




How would you compare this sedation 
experience to previous sedation 
experiences? 
Please Check one: 
□ Better 
□ Same 

















Key points to Remember 
It helps to be near and to comfort your child during the use of nitrous oxide. 
This gas is safe for use in children and there are no long term side effects. 
 
What is nitrous oxide? 
You may know this gas as happy gas or laughing gas. It is a sweet smelling, colorless gas 
used to ease pain and anxiety. 
 
How will it help my child? 
Your child may be offered nitrous oxide gas while the doctor or nurse carries out the 
procedure. The gas helps to ease the pain and anxiety your child may feel, but usually 
does not make them fall fully asleep. 
 
When your child starts to breathe the nitrous oxide, they will feel drowsy within a couple 
of minutes. The gas will be continued until the procedure finishes and will wear off 
quickly when the gas is stopped. This means your child can quickly get back to their 
usual activities (playing, eating etc.). 
 
How will it be given? 
Nitrous oxide will be given by a doctor. Before it is given, your child will be assessed to 
make sure this is the best option. You will be asked to make sure your child stops eating 
and drinking for a certain time before they have the gas (usually at least 2 hours, but may 
be longer if other sedating medicines will be used with the nitrous oxide). This helps 
reduce the risk of vomiting. 
 
Your child will be given a mask or a mouth piece attached to a machine through which 
they will breathe the gas. It can be helpful to look at, and play with the mask with your 
child before the procedure starts so your child is comfortable with it before it is placed on 
their face. 
 
You are welcome to stay while your child is having the gas. The best thing you can do is 
to stay where your child can see you and hold their hand. The gas will be given a few 
minutes before the procedure starts and will continue until it is finished. The gas may 
make your child feel 'floaty', warm and tingly. Your child may or may not remember 
anything about the procedure. 
 
When the nitrous oxide is stopped, your child will then be given oxygen through a mask 
to clear the gas from their lungs. After your child has had the oxygen and is awake and 




Are there any risks? 
This gas is safe for use in children and there are no long term side effects from occasional 
use. Young children may not like having a mask on their face. They may feel angry or 
confused by the mask and gas and will need you to stay close and comfort them. The 
nurse or doctor may need to hold the mask firmly over your child's face at first until the 
gas starts to work and your child relaxes. 
 
Other side effects may occur, but they are usually minor and get better quickly. Some 
children feel sick or vomit during nitrous oxide sedation. The staff looking after your 
child will know how to manage these problems if they occur. 
 
What can I do to help? 
Hospitals can be frightening places for children. If a child feels sick or is in pain, it can be 
upsetting to have nurses and doctors they don't know look after them. It helps if parents 
stay with their child to look after and comfort them during and after most procedures. If 
your child asks about the procedures being done, reassure them and explain in simple 
terms what is being done and why. Always tell the truth. 
 
At times it is helpful to tell stories, talk about the family or anything else that may help to 
take their mind off the procedure. Remain calm; if you get upset so will your child. The 
staff is there to help you and your child. If you would like more information please ask 
the nurse or doctor caring for your child. 
 
Child Life Specialists 
A Child Life Specialist is trained in helping children and families to cope effectively with 
procedures while in the hospital.  The CCLS will provide age appropriate teaching of 
procedures using medical dolls and age appropriate language to help the child to 
understand what will be happening during their stay. They will also provide distraction 
using toys, bubbles, soft music, and deep breathing throughout any procedures to keep 























QUOTATION FOR PORTER SENTRY SEDATE 
 








Demand Flow System 
PAK SENTRY H34-AV 
Porter Sentry Sedate 
MXR-1 Analog – 
Hospital Package    1 $9,750.00  $8,500.00  $8,500.00  
Accessories 
PAK80010 
O2 Hose – DISS/DISS 
Connect – 10ft 1 $231.00  $231.00  $231.00  
PAK 5602-DISSVAC 
Vacuum Quick 
Connect, DISS 1 $112.00  $112.00  $112.00  
PAKA-3399-000 
Replacement yoke 
washers 4 $2.00  $2.00  $8.00  
Disposables 
PAKSACA120 
Small Adult Full 
Facemask Breathing 
Circuit (box of 10) 2 $465.00  $290.00  $580.00  
PAKPDCA130 
Pediatric Full Facemask 
Breathing Circuit (box of 
10) 2 $465.00  $290.00  $580.00  
PAKYMCA140 
Youth Medium Full 
Facemask Breathing 
Circuit (box of 10) 2 $465.00  $290.00  $580.00  
            
  
    




    
Total Price AFTER 
discount 
$10,591.00  
      
Savings 
$2,300.00  
      18% 
            
            
Comments:  
 
Quotation Valid for 30 days 
Shipping and applicable taxes will be added to all orders 




Appendix K: Institutional Review Board Approval 
Walden University granted Institutional Review Board (IRB) approval of the project on 
March 18, 2016. HSHS St. Vincent Hospital also granted approval of the project on April 
11, 2016 (Appendix L). The IRB determined the project does not include the types of 
activities that require a traditional IRB review. This Confirmation of Ethical Standards 




Appendix L: IRB Approval HSHS St. Vincent Hospital 
 
 
 
